Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000671520 | SCV000796504 | uncertain significance | Lysosomal acid lipase deficiency | 2017-12-27 | criteria provided, single submitter | clinical testing | |
Alexion, |
RCV000671520 | SCV000999868 | likely pathogenic | Lysosomal acid lipase deficiency | 2019-06-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001868255 | SCV002131805 | uncertain significance | Wolman disease | 2022-07-25 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 86 of the LIPA protein (p.His86Tyr). This variant is present in population databases (rs749180806, gnomAD 0.01%). This missense change has been observed in individual(s) with lysosomal acid lipase deficiency (PMID: 28220406). ClinVar contains an entry for this variant (Variation ID: 555658). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LIPA protein function. Experimental studies have shown that this missense change affects LIPA function (PMID: 31180157). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |